From Bots to Docs: Harnessing AI in the Undergraduate Med School Journey. Talk given July 17, 2023, Umeds section of Association of Pathology Chairs.

Comments

Post a Comment

Popular posts from this blog

Thoughts on Large Language Models in pre-clinical medical education

  I gave a talk on AI/ LLM (aka ChatGPT and its cousins) in medical education at the UMEDS section of the Association of Pathology Chairs meeting July 17, 2023.  https://www.apcprods.org/apc2023 Some highlights. With respect to LLM, any literature from before 2022 is irrelevant. Forget the IBM Watson debacle. Generative LLM should be thought of in a different context than the various black box algorithms that predict patient outcome or classify images. I find those problematic as they distract from understanding the underlying biology. But LLM is different technology for different uses. With respect to education, there are two major categories of use cases. One is that the instructor can use LLM to generate an indefinitely large number of clinical scenarios and various questions for formative and summative learning exercises / tests. The system can generate harder or easier questions as needed. The material can be based on pasted in reference works or based on the LLM’s existi...
Read more

Thoughts on hypersensitivity pneumonitis

 Thoughts on pathology hypersensitivity pneumonitis from the newish ATS, ACCP consensus statement, and a review article by Andrew Churg  https://pubmed.ncbi.nlm.nih.gov/34531525 https://pubmed.ncbi.nlm.nih.gov/35738345 https://pubmed.ncbi.nlm.nih.gov/32706311 These criteria are designed primarily to provide a uniform language for clinical trials.   Nonetheless, they provide a platform to air general problems with current approaches. Both ATS and ACCP emphasize that HP should be thought of as non-fibrotic vs fibrotic rather than acute, subacute or chronic. This seems like a good thing but is basically relabeling how I (and presumably others) always thought of them with a more logical label. A precedent would be acute (cellular only) vs chronic/fibrotic interstitial nephritis. No attempt though is made to define how much fibrosis is needed to be labeled fibrotic e.g. is one reticulation on HRCT enough?  Lack of quantitation for all criteria is a problem throughout...
Read more

My shot...at revising ILD histopathology criteria

Image
  I had to do it. My Yale ancestors created UIP/DIP and the like (although they got those largely wrong, see my previous blog posts). So it is now my turn. While Tom Colby long ago relegated the wedge biopsy from gold to a silver standard, such biopsies are still considered potentially helpful. But how do we assess even a silver standard?  A few years ago, I felt frustrated that the biopsies I was looking at seemed difficult to classify and wanted additional input. I recruited an international group of pathologists with interest/expertise in ILD to review a series of cases using both fixed and whole slide images to see if we could improve our criteria. We have recently published this work (no paywall). https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-021-01522-6 For the truly curious, all the images used in this study are available online.   http://pathmodule.org/PathCamp/virtualslideshare/ The approach we took paralleled that taken by Carol Farver (a mem...
Read more